EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
27 hedge funds and large institutions have $13.6M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
60% less capital invested
Capital invested by funds: $33.9M → $13.6M (-$20.2M)
Holders
27
Holding in Top 10
3
Calls
$57K
Puts
–
Top Buyers
| 1 | +$95.2K | |
| 2 | +$32K | |
| 3 | +$27K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9K |
| 5 |
Millennium Management
New York
|
+$9K |
Top Sellers
| 1 | -$591K | |
| 2 | -$50.1K | |
| 3 | -$22K | |
| 4 |
PCM
Penserra Capital Management
Orinda,
California
|
-$7K |
| 5 |
Morgan Stanley
New York
|
-$625 |